The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global HER2 Antibodies Market Research Report 2024
Synopsis
The demand of HER2 Antibodies is increasing, and primarily gaining from growing awareness regarding the prevalence of HER2 positive breast cancer.
The global HER2 Antibodies market was valued at US$ 8287.1 million in 2023 and is anticipated to reach US$ 12010 million by 2030, witnessing a CAGR of 5.0% during the forecast period 2024-2030.
North American market for HER2 Antibodies is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for HER2 Antibodies is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for HER2 Antibodies in Hospital Pharmacies is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of HER2 Antibodies include Novartis, Pfizer, Roche, Abnova, InvivoGen, Celltrion, Biocon and Novus Biologicals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for HER2 Antibodies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding HER2 Antibodies.
Report Scope
The HER2 Antibodies market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global HER2 Antibodies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the HER2 Antibodies companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis
Pfizer
Roche
Abnova
InvivoGen
Celltrion
Biocon
Novus Biologicals
Segment by Type
Trastuzumab
Lapatinib
Ado-trastuzumab emtansine
Pertuzumab
Everolimus
Segment by Application
Hospital Pharmacies
Retail Pharmacies
E-commerce
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of HER2 Antibodies companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The demand of HER2 Antibodies is increasing, and primarily gaining from growing awareness regarding the prevalence of HER2 positive breast cancer.
The global HER2 Antibodies market was valued at US$ 8287.1 million in 2023 and is anticipated to reach US$ 12010 million by 2030, witnessing a CAGR of 5.0% during the forecast period 2024-2030.
North American market for HER2 Antibodies is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for HER2 Antibodies is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for HER2 Antibodies in Hospital Pharmacies is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of HER2 Antibodies include Novartis, Pfizer, Roche, Abnova, InvivoGen, Celltrion, Biocon and Novus Biologicals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for HER2 Antibodies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding HER2 Antibodies.
Report Scope
The HER2 Antibodies market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global HER2 Antibodies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the HER2 Antibodies companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis
Pfizer
Roche
Abnova
InvivoGen
Celltrion
Biocon
Novus Biologicals
Segment by Type
Trastuzumab
Lapatinib
Ado-trastuzumab emtansine
Pertuzumab
Everolimus
Segment by Application
Hospital Pharmacies
Retail Pharmacies
E-commerce
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of HER2 Antibodies companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global HER2 Antibodies Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Trastuzumab
1.2.3 Lapatinib
1.2.4 Ado-trastuzumab emtansine
1.2.5 Pertuzumab
1.2.6 Everolimus
1.3 Market by Application
1.3.1 Global HER2 Antibodies Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 E-commerce
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global HER2 Antibodies Market Perspective (2019-2030)
2.2 HER2 Antibodies Growth Trends by Region
2.2.1 Global HER2 Antibodies Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 HER2 Antibodies Historic Market Size by Region (2019-2024)
2.2.3 HER2 Antibodies Forecasted Market Size by Region (2025-2030)
2.3 HER2 Antibodies Market Dynamics
2.3.1 HER2 Antibodies Industry Trends
2.3.2 HER2 Antibodies Market Drivers
2.3.3 HER2 Antibodies Market Challenges
2.3.4 HER2 Antibodies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top HER2 Antibodies Players by Revenue
3.1.1 Global Top HER2 Antibodies Players by Revenue (2019-2024)
3.1.2 Global HER2 Antibodies Revenue Market Share by Players (2019-2024)
3.2 Global HER2 Antibodies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by HER2 Antibodies Revenue
3.4 Global HER2 Antibodies Market Concentration Ratio
3.4.1 Global HER2 Antibodies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by HER2 Antibodies Revenue in 2023
3.5 HER2 Antibodies Key Players Head office and Area Served
3.6 Key Players HER2 Antibodies Product Solution and Service
3.7 Date of Enter into HER2 Antibodies Market
3.8 Mergers & Acquisitions, Expansion Plans
4 HER2 Antibodies Breakdown Data by Type
4.1 Global HER2 Antibodies Historic Market Size by Type (2019-2024)
4.2 Global HER2 Antibodies Forecasted Market Size by Type (2025-2030)
5 HER2 Antibodies Breakdown Data by Application
5.1 Global HER2 Antibodies Historic Market Size by Application (2019-2024)
5.2 Global HER2 Antibodies Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America HER2 Antibodies Market Size (2019-2030)
6.2 North America HER2 Antibodies Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America HER2 Antibodies Market Size by Country (2019-2024)
6.4 North America HER2 Antibodies Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe HER2 Antibodies Market Size (2019-2030)
7.2 Europe HER2 Antibodies Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe HER2 Antibodies Market Size by Country (2019-2024)
7.4 Europe HER2 Antibodies Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific HER2 Antibodies Market Size (2019-2030)
8.2 Asia-Pacific HER2 Antibodies Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific HER2 Antibodies Market Size by Region (2019-2024)
8.4 Asia-Pacific HER2 Antibodies Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America HER2 Antibodies Market Size (2019-2030)
9.2 Latin America HER2 Antibodies Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America HER2 Antibodies Market Size by Country (2019-2024)
9.4 Latin America HER2 Antibodies Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa HER2 Antibodies Market Size (2019-2030)
10.2 Middle East & Africa HER2 Antibodies Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa HER2 Antibodies Market Size by Country (2019-2024)
10.4 Middle East & Africa HER2 Antibodies Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Detail
11.1.2 Novartis Business Overview
11.1.3 Novartis HER2 Antibodies Introduction
11.1.4 Novartis Revenue in HER2 Antibodies Business (2019-2024)
11.1.5 Novartis Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Detail
11.2.2 Pfizer Business Overview
11.2.3 Pfizer HER2 Antibodies Introduction
11.2.4 Pfizer Revenue in HER2 Antibodies Business (2019-2024)
11.2.5 Pfizer Recent Development
11.3 Roche
11.3.1 Roche Company Detail
11.3.2 Roche Business Overview
11.3.3 Roche HER2 Antibodies Introduction
11.3.4 Roche Revenue in HER2 Antibodies Business (2019-2024)
11.3.5 Roche Recent Development
11.4 Abnova
11.4.1 Abnova Company Detail
11.4.2 Abnova Business Overview
11.4.3 Abnova HER2 Antibodies Introduction
11.4.4 Abnova Revenue in HER2 Antibodies Business (2019-2024)
11.4.5 Abnova Recent Development
11.5 InvivoGen
11.5.1 InvivoGen Company Detail
11.5.2 InvivoGen Business Overview
11.5.3 InvivoGen HER2 Antibodies Introduction
11.5.4 InvivoGen Revenue in HER2 Antibodies Business (2019-2024)
11.5.5 InvivoGen Recent Development
11.6 Celltrion
11.6.1 Celltrion Company Detail
11.6.2 Celltrion Business Overview
11.6.3 Celltrion HER2 Antibodies Introduction
11.6.4 Celltrion Revenue in HER2 Antibodies Business (2019-2024)
11.6.5 Celltrion Recent Development
11.7 Biocon
11.7.1 Biocon Company Detail
11.7.2 Biocon Business Overview
11.7.3 Biocon HER2 Antibodies Introduction
11.7.4 Biocon Revenue in HER2 Antibodies Business (2019-2024)
11.7.5 Biocon Recent Development
11.8 Novus Biologicals
11.8.1 Novus Biologicals Company Detail
11.8.2 Novus Biologicals Business Overview
11.8.3 Novus Biologicals HER2 Antibodies Introduction
11.8.4 Novus Biologicals Revenue in HER2 Antibodies Business (2019-2024)
11.8.5 Novus Biologicals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
